<!doctype html>
<html class="no-js" lang="es">

<head>
  <meta charset="utf-8">
  <title></title>
  <meta name="description" content="">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link rel="stylesheet" href="assets/css/normalize.css">
  <link rel="stylesheet" href="assets/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/css/owl.carousel.min.css">
  <link rel="stylesheet" href="assets/css/main.css">
  <link rel="stylesheet" href="assets/css/lightbox.min.css"/>

  <meta name="theme-color" content="#fafafa">
</head>

<body>

  <header id="header"></header>

  <section class="page-header">
    <div class="container">
      <div class="row ">
        <div class="col-6 align-self-center">
          <h2>Publicacions</h2>
        </div>
        <div class="col-6">
          <div class="page-header-image" style="background:url('./assets/img/publicacions.png');background-size:cover;"></div>
        </div>
      </div>
    </div>
  </section>

  <section class="publicacions-list">
    <div class="container">

      <div class="publicacion-box">
        <div class="row gx-6">
          <div class="col-lg-6">

            <ul>
              <li>Anne E Rosser, Monica Busse, Romina Aron Badin, Josep M Canals, Vicki Wheelock, Anselme L Perrier, William Gray, Leslie Thompson, Steven Goldman; Cell Therapy for Huntington's Disease: Learning from Failure; Mov Disord. 2021 Mar;36(3):787-788.</li>

              <li>Romina Aron Badin, Anne-Catherine Bachoud-Lévi, Gerhard Bauer, Monica Busse-Morris, Josep M Canals, Philipp Capetian, Elena Cattaneo, Jefferson Chen, Emanuele Cozzi, Zdenka Ellederova, Steven A Goldman, William Gray, Liangxue Lai , Meng Li, Anna Morenkova, Guangjin Pan , Zhong Pei, Unai Perpina Martin, Anselme Perrier, John C Reidling, Anne E Rosser, Jiwhan Song, Leslie M Thompson, Vicki Wheelock; Stem Cells for Huntington's Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease; J Huntingtons Dis . 2021 Feb 26.</li>

              <li>Valentín Ortíz-Maldonado, Susana Rives, Maria Castellà, Anna Alonso-Saladrigues, Daniel Benítez-Ribas, Miguel Caballero-Baños, Tycho Baumann, Joan Cid, Enric Garcia-Rey, Cristina Llanos, Montserrat Torrebadell, Neus Villamor, Eva Giné, Marina Díaz-Beyá, Laia Guardia, Mercedes Montoro, Albert a, Anna Faura, E Azucena González,Marta Español-Rego, Nela Klein-González, Laia Alsina, Pedro Castro,Iolanda Jordan, Sara Fernández, Federico Ramos, Guillermo Suñé, Unai Perpiñá, Josep M Canals, Miquel Lozano, Esteve Trias, Andrea Scalise, Sara Varea, Joaquín Sáez-Peñataro, Ferran Torres, Gonzalo Calvo, Jordi Esteve, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado; CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19 + Relapsed/Refractory Malignancies; Mol Ther. 2021 Feb 3;29(2):636-644.</li>

              <li>>Salado-Manzano C, Perpiña U, Straccia M, Molina-Ruiz FJ, Cozzi E, Rosser AE, Canals JM. Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases? Front Cell Neurosci. 2020  14:250.</li>

              <li>Vidal-Sancho L, Fernández-García S, Solés-Tarrés I, Alberch J, Xifró X. Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction. Mol Neurobiol. 2020 57(11):4549-4562.</li>

              <li>Martín-Flores N, Pérez-Sisqués L, Creus-Muncunill J, Masana M, Ginés S, Alberch J, Pérez-Navarro E, Malagelada C. Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease. Cell Death Dis. 2020 11(7):569.</li>

              <li>Kim A, García-García E, Straccia M, Comella-Bolla A, Miguez A, Masana M, Alberch J, Canals JM, Rodríguez MJ. Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease. Front Cell Neurosci. 2020 14:163.</li>
            </ul>

          </div>
          <div class="col-lg-6">

            <ul>
              <li>Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, Canela EI, Ginés S, McCormick PJ. Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. Elife. 2020 9:e51093.</li>

              <li>Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, Canela EI, Ginés S, McCormick PJ. Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. Elife. 2020 9:e51093.</li>

              <li>Fernández-García S, Sancho-Balsells A, Longueville S, Hervé D, Gruart A, Delgado-García JM, Alberch J, Giralt A. Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy. Cell Death Dis. 2020 11(6):411.</li>

              <li>Fernández-García S, Orlandi JG, García-Díaz Barriga GA, Rodríguez MJ, Masana M, Soriano J, Alberch J. Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease. BMC Biol. 2020 18(1):58.</li>

              <li>Llorach-Pares L, Rodriguez-Urgelles E, Nonell-Canals A, Alberch J, Avila C, Sanchez-Martinez M, Giralt A. Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity. Biomolecules. 2020 10(4):639.</li>

              <li>Castella M, Caballero-Baños M, Ortiz-Maldonado V, González-Navarro EA, Suñé G, Antoñana-Vidósola A, Boronat A, Marzal B, Millán L, Martín-Antonio B, Cid J, Lozano M, García E, Tabera J, Trias E, Perpiña U, Canals JM, Baumann T, Benítez-Ribas D, Campo E, Yagüe J, Urbano-Ispizua Á, Rives S, Delgado J, Juan M. Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial. Front Immunol. 2020 11:482.</li>

              <li>Sancho-Balsells A, Brito V, Fernández B, Pardo M, Straccia M, Ginés S, Alberch J, Hernández I, Arranz B, Canals JM, Giralt A. Lack of Helios During Neural Development Induces Adult Schizophrenia-Like Behaviors Associated With Aberrant Levels of the TRIF-Recruiter Protein WDFY1. Front Cell Neurosci. 2020 14:93.</li>

              <li>Comella-Bolla A, Orlandi JG, Miguez A, Straccia M, García-Bravo M, Bombau G, Galofré M, Sanders P, Carrere J, Segovia JC, Blasi J, Allen ND, Alberch J, Soriano J, Canals JM. Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation. Mol Neurobiol. 2020 57(6):2766-2798.</li>
            </ul>

          </div>
        </div><!-- /.row -->
      </div><!-- /.publicacion -->

      <div class="publicacion-box">
        <div class="row gx-6">
          <div class="col-lg-6">

            <ul>
              <li>Anne E Rosser, Monica Busse, Romina Aron Badin, Josep M Canals, Vicki Wheelock, Anselme L Perrier, William Gray, Leslie Thompson, Steven Goldman; Cell Therapy for Huntington's Disease: Learning from Failure; Mov Disord. 2021 Mar;36(3):787-788.</li>

              <li>Romina Aron Badin, Anne-Catherine Bachoud-Lévi, Gerhard Bauer, Monica Busse-Morris, Josep M Canals, Philipp Capetian, Elena Cattaneo, Jefferson Chen, Emanuele Cozzi, Zdenka Ellederova, Steven A Goldman, William Gray, Liangxue Lai , Meng Li, Anna Morenkova, Guangjin Pan , Zhong Pei, Unai Perpina Martin, Anselme Perrier, John C Reidling, Anne E Rosser, Jiwhan Song, Leslie M Thompson, Vicki Wheelock; Stem Cells for Huntington's Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease; J Huntingtons Dis . 2021 Feb 26.</li>

              <li>Valentín Ortíz-Maldonado, Susana Rives, Maria Castellà, Anna Alonso-Saladrigues, Daniel Benítez-Ribas, Miguel Caballero-Baños, Tycho Baumann, Joan Cid, Enric Garcia-Rey, Cristina Llanos, Montserrat Torrebadell, Neus Villamor, Eva Giné, Marina Díaz-Beyá, Laia Guardia, Mercedes Montoro, Albert a, Anna Faura, E Azucena González,Marta Español-Rego, Nela Klein-González, Laia Alsina, Pedro Castro,Iolanda Jordan, Sara Fernández, Federico Ramos, Guillermo Suñé, Unai Perpiñá, Josep M Canals, Miquel Lozano, Esteve Trias, Andrea Scalise, Sara Varea, Joaquín Sáez-Peñataro, Ferran Torres, Gonzalo Calvo, Jordi Esteve, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado; CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19 + Relapsed/Refractory Malignancies; Mol Ther. 2021 Feb 3;29(2):636-644.</li>

              <li>>Salado-Manzano C, Perpiña U, Straccia M, Molina-Ruiz FJ, Cozzi E, Rosser AE, Canals JM. Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases? Front Cell Neurosci. 2020  14:250.</li>

              <li>Vidal-Sancho L, Fernández-García S, Solés-Tarrés I, Alberch J, Xifró X. Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction. Mol Neurobiol. 2020 57(11):4549-4562.</li>

              <li>Martín-Flores N, Pérez-Sisqués L, Creus-Muncunill J, Masana M, Ginés S, Alberch J, Pérez-Navarro E, Malagelada C. Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease. Cell Death Dis. 2020 11(7):569.</li>

              <li>Kim A, García-García E, Straccia M, Comella-Bolla A, Miguez A, Masana M, Alberch J, Canals JM, Rodríguez MJ. Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease. Front Cell Neurosci. 2020 14:163.</li>
            </ul>

          </div>
          <div class="col-lg-6">

            <ul>
              <li>Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, Canela EI, Ginés S, McCormick PJ. Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. Elife. 2020 9:e51093.</li>

              <li>Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, Canela EI, Ginés S, McCormick PJ. Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. Elife. 2020 9:e51093.</li>

              <li>Fernández-García S, Sancho-Balsells A, Longueville S, Hervé D, Gruart A, Delgado-García JM, Alberch J, Giralt A. Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy. Cell Death Dis. 2020 11(6):411.</li>

              <li>Fernández-García S, Orlandi JG, García-Díaz Barriga GA, Rodríguez MJ, Masana M, Soriano J, Alberch J. Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease. BMC Biol. 2020 18(1):58.</li>

              <li>Llorach-Pares L, Rodriguez-Urgelles E, Nonell-Canals A, Alberch J, Avila C, Sanchez-Martinez M, Giralt A. Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity. Biomolecules. 2020 10(4):639.</li>

              <li>Castella M, Caballero-Baños M, Ortiz-Maldonado V, González-Navarro EA, Suñé G, Antoñana-Vidósola A, Boronat A, Marzal B, Millán L, Martín-Antonio B, Cid J, Lozano M, García E, Tabera J, Trias E, Perpiña U, Canals JM, Baumann T, Benítez-Ribas D, Campo E, Yagüe J, Urbano-Ispizua Á, Rives S, Delgado J, Juan M. Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial. Front Immunol. 2020 11:482.</li>
            </ul>

          </div>
        </div><!-- /.row -->
      </div><!-- /.publicacion -->

      <div class="row mt-4 pt-1">
        <div class="col text-center">
          <div class="cta-primary cta-primary-dark-blue cta-primary-plus" id="loadMore">
            <span>VEURE MÉS</span>
            <span class="plus"></span>
          </div>
        </div>
      </div><!-- /.row -->

    </div><!-- /.container -->
  </section>

  <footer id="footer"></footer>

  <script src="assets/js/jquery-3.6.0.min.js"></script>
  <script src="assets/js/bootstrap.min.js"></script>
  <script src="assets/js/owl.carousel.min.js"></script>
  <script src="assets/js/plugins.js"></script>
  <script src="assets/js/main.js"></script>
  <script src="assets/js/lightbox.min.js"></script>

  <script>
    $(function(){
      $("#header").load("includes/header.html", function() {
        $('li.nav-item-actualitat').addClass('active');
      });
      $("#footer").load("includes/footer.html");
    });
  </script>

  <!-- Google Analytics: change UA-XXXXX-Y to be your site's ID. -->
  <script>
    window.ga = function () { ga.q.push(arguments) }; ga.q = []; ga.l = +new Date;
    ga('create', 'UA-XXXXX-Y', 'auto'); ga('set', 'anonymizeIp', true); ga('set', 'transport', 'beacon'); ga('send', 'pageview')
  </script>
  <script src="https://www.google-analytics.com/analytics.js" async></script>
</body>

</html>
